Stanimirov, Bojan
41  results:
Search for persons X
?
4

PAMPA model of gliclazide permeability: The impact of probi..:

Đanić, Maja ; Pavlović, Nebojša ; Stanimirov, Bojan...
European Journal of Pharmaceutical Sciences.  158 (2021)  - p. 105668 , 2021
 
?
5

DPP-4 Inhibitors: Renoprotective Potential and Pharmacokine..:

Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan...
European Journal of Drug Metabolism and Pharmacokinetics.  45 (2019)  1 - p. 1-14 , 2019
 
?
9

Potential Applications of Gliclazide in Treating Type 1 Dia..:

Mikov, Momir ; Đanić, Maja ; Pavlović, Nebojša...
European Journal of Drug Metabolism and Pharmacokinetics.  43 (2017)  3 - p. 269-280 , 2017
 
?
11

The Role of Drug Metabolites in the Inhibition of Cytochrom..:

Mikov, Momir ; Đanić, Maja ; Pavlović, Nebojša...
European Journal of Drug Metabolism and Pharmacokinetics.  42 (2017)  6 - p. 881-890 , 2017
 
?
13

Bile acid signaling through farnesoid X and TGR5 receptors ..:

Stanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir
Hepatobiliary & Pancreatic Diseases International.  14 (2015)  1 - p. 18-33 , 2015
 
1-15